|
Market Closed -
Nasdaq
16:00:00 2026-09-17 EDT
|
5-day change | 1st Jan Change | ||
| 2.700 USD | +0.75% |
|
+2.66% | +65.64% |
| 08-13 | Ovid Therapeutics Reports Pipeline and Business Updates | CI |
| 08-13 | Ovid Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.75% | +2.66% | -6.57% | +11.57% | +65.64% | +132.76% | -31.99% | -19.88% | - | 523M | |
| +1.76% | +3.62% | +0.78% | +63.50% | +77.06% | +49.92% | +101.12% | +11.33% | - | 69.69B | |
| +2.29% | +1.43% | +1.50% | +11.25% | +21.09% | +38.39% | +77.03% | +209.89% | +5,629.37% | 61.24B | |
| +1.14% | -2.59% | -3.38% | +25.93% | -28.76% | -14.37% | +365.92% | +362.96% | +750.93% | 26.77B | |
| +0.32% | +5.47% | +8.54% | +67.78% | +59.35% | +27.74% | +14.12% | -59.30% | - | 26.12B | |
| +2.95% | +2.34% | +7.71% | +6.98% | +3.63% | +0.52% | -12.74% | -72.53% | - | 24.07B | |
| +1.49% | +7.73% | +6.65% | +37.00% | +10.71% | +26.85% | -15.89% | -16.89% | +103.45% | 20.39B | |
| -0.83% | -9.47% | -15.25% | +31.25% | +182.04% | +174.16% | +295.44% | +1,429.15% | +726.43% | 15.72B | |
| +3.01% | +1.85% | +11.79% | +11.54% | +33.45% | +44.63% | +168.18% | +182.29% | +331.66% | 14.07B | |
| +0.17% | -2.74% | -11.69% | +14.38% | +17.64% | -9.79% | +484.05% | - | - | 14.03B | |
| +2.43% | +4.24% | +38.65% | +25.94% | +1.32% | -2.05% | +847.59% | +177.74% | +197.82% | 13.8B | |
| +1.00% | +0.24% | +1.82% | +6.91% | -8.23% | +28.02% | +203.83% | +553.78% | +5,325.38% | 12.22B | |
| +0.39% | -3.04% | +0.28% | +8.16% | -19.69% | -29.65% | +140.40% | +112.78% | - | 10.61B | |
| +2.96% | -18.15% | -23.63% | -16.41% | +2.03% | +132.54% | +134.23% | +4.33% | +856.78% | 9.29B | |
| +0.76% | -5.03% | -7.84% | -10.49% | +10.04% | +47.01% | +104.27% | +106.31% | +709.26% | 9.65B | |
| +2.72% | +2.50% | +0.25% | +19.14% | +30.84% | +95.47% | +16.72% | +138.05% | - | 8.75B | |
| +6.95% | +9.59% | +6.82% | +21.03% | +327.27% | +206.52% | +370.00% | -16.90% | - | 8.38B | |
| +0.34% | -0.40% | -8.41% | +9.94% | +2.92% | -30.23% | +89.03% | -27.85% | - | 8.02B | |
| +1.66% | +4.48% | -11.40% | +5.93% | +182.91% | +515.81% | +566.76% | -50.37% | -51.92% | 8.04B | |
| +0.67% | -2.70% | +4.37% | +14.84% | +6.50% | +133.36% | +429.04% | - | - | 6.81B | |
| Average | +1.65% | -0.79% | +0.05% | +18.31% | +48.89% | +78.38% | +217.36% | +168.05% | +1,457.92% | 18.41B | |
| Weighted average by Cap. | +1.69% | +0.62% | +1.50% | +27.73% | +42.74% | +51.85% | +175.06% | +163.12% | +2,433.44% |
- Stock Market
- Stocks
- OVID Stock
- Sector Ovid Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
